Delivery Order SPE2DB20D3303-SPE2DB24FZ4A4

Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,177.78 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Lacosamide 10 mg/ml solution in 200ml bottles. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563830313 - Lacosamide 10 mg/ml solution 200 ml. The contract has a completion date of March 4, 2024 and a potential value of $1,450.26. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,747.54 firm fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution in 200 ml vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of lacosamide 10 mg/ml solution in 200 ml containers. The contract has a firm-fixed price of $2,372.32 and an ultimate completion date of September 9, 2024. The contract was not set aside for any special category of businesses. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $7,970.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lacosamide 10 mg/ml solution in 200 ml containers. The award has a ceiling value of $1,652.86 and a completion date of September 25, 2024. It is a firm-fixed-price contract with no set-aside designation. As a large distributor, AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other agencies,...
This federal contract award, valued at $3,996.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. It has an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $1,250.15 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lacosamide 50 mg/5 ml cups with an ultimate completion date of March 21, 2024. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver...
This federal contract award is for the delivery of Lacosamide 10 mg/ml solution in 200 ml vials to the Defense Logistics Agency (DLA). The contract, valued at $1,381.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 22, 2023. The contract has a completion date of August 23, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
This federal contract award, valued at $4,542.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml quantities, a pharmaceutical product used for medical treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FZ4A4
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,565.03 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lacosamide 10 mg/ml solution in 200 ml vials. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceuticals and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. Amerisourcebergen Corporation, the parent company of the prime contractor, is a leading global pharmaceutical sourcing and distribution services company.

Generated 7/8/24, 9:16 AM